The present invention relates to antibodies and related molecules that specifically bind to the Nogo receptor (NogoR). Such antibodies have uses, for example, in the treatment of spinal cord injury, brain trauma, paralysis, degenerative nervous system diseases, and stroke. The invention also relates to nucleic acid molecules encoding anti-NogoR antibodies, vectors and host cells containing these nucleic acids, and methods for producing the same.

 
Web www.patentalert.com

< Diarylheptanoid compounds and uses thereof

< Biological polymer with differently charged portions

> Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI

> Methods for using pet measured metabolism to determine cognitive impairment

~ 00211